Case-control study of medical history and idiopathic pulmonary fibrosis in Japan

Respirology

Volumn 10, Issue 4, 2005, Pages 504-509

  Miyake, Yoshihiro ^a   Sasaki, Satoshi ^b   Yokoyama, Tetsuji ^c   Chida, Kingo ^d   Azuma, Arata ^e   Suda, Takafumi ^d   Kudoh, Shoji ^e   Sakamoto, Naomasa ^f   Okamoto, Kazushi ^g   Kobashi, Gen ^h   Washio, Masakazu ⁱ   Inaba, Yutaka ^j   Tanaka, Heizo ^b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f HYOGO COLLEGE OF MEDICINE   (Japan)

^g Aichi Prefectural College of Nursing and Health   (Japan)

^h HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Case control studies; Hay fever; Japan; Pulmonary fibrosis

Indexed keywords

ADULT; AGE; AGED; ALLERGIC RHINITIS; ANAMNESIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BACTERIAL PNEUMONIA; BODY MASS; CASE CONTROL STUDY; CLINICAL TRIAL; COMMON COLD; DIABETES MELLITUS; DISEASE ASSOCIATION; EMPLOYMENT; FEMALE; GENDER; GENETIC PREDISPOSITION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; JAPAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCUPATIONAL EXPOSURE; OUTPATIENT; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TUBERCULOSIS; COMORBIDITY; MIDDLE AGED; QUESTIONNAIRE; RISK; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; ODDS RATIO; PULMONARY FIBROSIS; QUESTIONNAIRES;

EID: 33644840719     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00742.x     Document Type: Article

References (16)

1. Selman M King TE Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001 134 : 136 51.
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am. J. Respir. Crit. Care Med. 2000 161 : 646 64.
3. Enomoto T Usuki J Azuma A Nakagawa T Kudoh S. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. Chest 2003 123 : 2007 11.
4. Marsh P Johnston I Britton J. Atopy as a risk factor for cryptogenic fibrosing alveolitis. Respir. Med. 1994 88 : 369 71.
5. Ueda T Ohta K Suzuki N et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am. Rev. Respir. Dis. 1992 146 : 266 8.
6. Meliconi R Andreone P Fasano L et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996 51 : 315 17.
7. Irving WL Day S Johnston IDA. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am. Rev. Respir. Dis. 1993 148 : 1683 4.
8. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002 165 : 277 304.
9. Sasaki S Yanagibori R Amano K. Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J. Epidemiol. 1998 8 : 203 15.
10. Sasaki S Ushio F Amano K et al. Serum biomarker-based validation of a self-administered diet history questionnaire for Japanese subjects. J. Nutr. Sci. Vitaminol. 2000 46 : 285 96.
11. Yura A Shimizu T. Trends in the prevalence of atopic dermatitis in school children: longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997. Br. J. Dermatol. 2001 145 : 966 73.
12. Sakurai Y Nakamura K Teruya K et al. Prevalence and risk factors of allergic rhinitis and cedar pollinosis among Japanese men. Prev. Med. 1998 27 : 617 22.
13. Matsuse T Ohga E Teramoto S et al. Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J. Clin. Pathol. 1998 51 : 515 19.
14. Usuki J Enomoto T Azuma A Matsuda K Aoyama A Kudoh S. Influence of hyperglycemia to the severity of pulmonary fibrosis. Chest 2001 120 ( Suppl. 1 71S.
15. Egan JJ Woodcock AA Stewart JP. Viruses and idiopathic pulmonary fibrosis. Eur. Respir. J. 1997 10 : 1433 7.
16. Miyake Y, Fukuoka Heart Study Group. Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese. Jpn. Circ. J. 2000 64 : 103 9.